United States Government Publishing Office publisher pbl distributor dst United States National Archives and Records Administration Office of the Federal Register author aut Government Organization text government publication eng FR Regulatory Information 2011_register executive 2011-09-29 article Notices D09002ee1c7ff3bc5 D09002ee1c7ff3c6e United States Department of Health and Human Services originator org United States Government Agency or Subagency United States National Institutes of Health originator org United States Government Agency or Subagency This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i), that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive patent license to practice the inventions embodied in U.S. Provisional Patent Application No. 60/178,689, filed January 28, 2000 [HHS Ref. No. E-088-2000/0-US-01], now expired; PCT Patent Application No. PCT/US01/02686 [HHS Ref. No. E-088-2000/0-PCT-02] filed January 26, 2001, which published as WO/2001/54718 on August 2, 2001, now expired; U.S. Patent No. 7,431,931 [HHS Ref. No. E-088-2000/0-US-06]; Australian Patent No. 784344 [HHS Ref. No. E-088-2000/0-AU-04]; German Patent No. 60141681.308 [HHS Ref. No. E-088-2000/0-DE-08]; French Patent No. 1251869 [HHS Ref. No. E-088-2000/0-FR-09]; United Kingdom Patent No. 1251869 [HHS Ref. No. E-088-2000/0-GB-10]; and Canadian Patent Application No. 2398428 [HHS Ref. No. E-088-2000/0-CA-05], entitled "Compositions and Method for Preventing Reactogenicity Associated with Administration of Immunogenic Live Rotavirus Compositions," and all continuing applications to International Medica Foundation, having a place of business in Rochester, Minnesota. The patent rights in these inventions have been assigned to the United States of America. The prospective exclusive license territory may be "worldwide", and the field of use may be limited to "rhesus-based rotavirus therapeutic and/or prophylactic vaccines." 76 FR 60510 https://www.govinfo.gov/app/details/FR-2011-09-29/2011-25098 2011-25098 fr29se11-92 4140-01-P https://www.govinfo.gov/app/details/FR-2011-09-29/2011-25098 https://www.govinfo.gov/content/pkg/FR-2011-09-29/html/2011-25098.htm https://www.govinfo.gov/content/pkg/FR-2011-09-29/pdf/2011-25098.pdf 1 p. 60510 60510 76 FR 60510 Prospective Grant of Exclusive License: Compositions and Method for Preventing Reactogenicity Associated with Administration of Immunogenic Live Rotavirus Compositions; Federal Register Vol. 76, Issue NOTICE 2011-25098 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health 2011-10-31 4140-01-P 2011-25098 Notice.

This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i), that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive patent license to practice the inventions embodied in U.S. Provisional Patent Application No. 60/178,689, filed January 28, 2000 [HHS Ref. No. E-088-2000/0-US-01], now expired; PCT Patent Application No. PCT/US01/02686 [HHS Ref. No. E-088-2000/0-PCT-02] filed January 26, 2001, which published as WO/2001/54718 on August 2, 2001, now expired; U.S. Patent No. 7,431,931 [HHS Ref. No. E-088-2000/0-US-06]; Australian Patent No. 784344 [HHS Ref. No. E-088-2000/0-AU-04]; German Patent No. 60141681.308 [HHS Ref. No. E-088-2000/0-DE-08]; French Patent No. 1251869 [HHS Ref. No. E-088-2000/0-FR-09]; United Kingdom Patent No. 1251869 [HHS Ref. No. E-088-2000/0-GB-10]; and Canadian Patent Application No. 2398428 [HHS Ref. No. E-088-2000/0-CA-05], entitled "Compositions and Method for Preventing Reactogenicity Associated with Administration of Immunogenic Live Rotavirus Compositions," and all continuing applications to International Medica Foundation, having a place of business in Rochester, Minnesota. The patent rights in these inventions have been assigned to the United States of America. The prospective exclusive license territory may be "worldwide", and the field of use may be limited to "rhesus-based rotavirus therapeutic and/or prophylactic vaccines."

Only written comments and/or applications for a license which are received by the NIH Office of Technology Transfer on or before October 31, 2011 will be considered. Prospective Grants of Exclusive Licenses: Compositions and Method for Preventing Reactogenicity Associated with Administration of Immunogenic Live Rotavirus Compositions , changke@mail.nih.gov Vol. 76, no. 189 Office of the Federal Register, National Archives and Records Administration 2011-09-29 continuing daily deposited born digital 355 p. Table of Contents: AE 2.7: GS 4.107: AE 2.106: KF70.A2 https://www.govinfo.gov/app/details/FR-2011-09-29 P0b002ee180e20d3a 0097-6326 0042-1219 0364-1406 769-004-00000-9 000582072 f:fr29se11 https://www.govinfo.gov/app/details/FR-2011-09-29 https://www.govinfo.gov/content/pkg/FR-2011-09-29/pdf/FR-2011-09-29.pdf https://www.govinfo.gov/content/pkg/FR-2011-09-29/xml/FR-2011-09-29.xml fdlp 60357 60700 DGPO 2011-09-29 2024-06-03 FR-2011-09-29 machine generated eng FR FR-2011-09-29 76 189